Filed Under News, What's New 

Les Jordan Joins Target Health as Vice President, Chief Product Evangelist


As part of Target Health’s commitment to the paperless clinical trial, we welcome Les Jordan to Target Health as Vice President and Chief Product Evangelist. Les’ mandate is to provide overall software product vision, architectural and technical guidance to our esteemed software development teams, and support for sales and marketing. Les brings to Target Health almost 20 years of Life Science industry experience and over 25 years of IT and IS management experience. His particular expertise includes systems that support clinical trials, and a passion for bringing patient engagement technologies to clinical trials.


Les spent 10 years as the CTO for Microsoft’s Life Sciences Industry Unit, where he was responsible for providing Life Science industry guidance to internal product teams particularly around regulatory compliance, and working with the largest Life Science companies on how to use Microsoft products to solve industry problems. He also served as Microsoft’s representative to industry standards groups, including CDISC, IHE and HL7.  After he left Microsoft, Les spent two years with Quintiles where he was responsible for sales and marketing for their IT Consulting Practice and 5 years with Webridge (now part of Huron Consulting) where he was responsible for launching their now market-leading suite of products into clinical trials and research compliance automation.


Les started his career at Boston Biostatistics (now part of Icon) as the IT Director and fourth employee, working with our good friend and colleague Dr. Phil Lavin. His responsibilities included the design and development of electronic data capture systems, installing client-server based clinical trials systems at many of the largest pharmaceutical and life sciences companies, and consulting with customers on the implementation of CANDA systems supporting drug filings to FDA.


Outside of pharmaceutical and life sciences companies, Les served six years in the financial services industry, with most of the time as an officer at State Street Bank, a Fortune 500 financial services firm, managing large IT projects and setting direction in the messaging and collaboration space. His efforts have resulted in invitations to speak at numerous conferences, events, and webinars on life science topics, as well as numerous interviews and articles published in publications including BioInform, ClinPage, Pharmaceutical Manufacturing, BioIT World, Applied Clinical Trials and Applied & Translational Genomics.


In his spare time, Les volunteers as a music teacher working with inner city children, designs web sites for local non-profits, and has served for almost 10 years as the Tournament Director for his local youth soccer association.


We are now setting up partnering meetings with large and small pharma companies, large and small CROs and independents to truly transform the industry. Our paperless and web-based solutions, with no need for any dedicated devices, include 1) direct data entry (eSource) at the time of the office visit, 2) integration with the electronic medical record (EMR), 3) electronic Informed Consent and 4) multiple clinical trial features, all at one website. Thus, the former, together with our expertise in drug and device development, and Target Health and 8 clinical sites passing FDA inspections of our software, and especially one FDA marketing approval, says it all.


No study is too small. We will pilot for those who just want to dip their toes in the water.


For more information about Target Health contact Warren Pearlson (212-681-2100 ext. 165). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel or Ms. Joyce Hays. The Target Health software tools are designed to partner with both CROs and Sponsors. Please visit the Target Health Website, and if you like the weekly newsletter, ON TARGET, you’ll love the Blog.


Joyce Hays, Founder and Editor in Chief of On Target

Jules Mitchel, Editor



Leave a Reply

You must be logged in to post a comment.